Orbit summarizes health news from several newsrooms. It is not medical advice. Talk to a doctor or pharmacist about your own health.
At a glance
- Experimental drugs designed to reduce heart disease risk factors failed to lower rates of heart attack or stroke.23
- Full clinical data indicated that the experimental treatments performed no better than placebos.12
- The unexpected trial results raised broader questions among experts regarding cardiovascular treatment strategies.13
Clinical trial results revealed that experimental cardiovascular drugs failed to reduce patient risk for heart attack or stroke.23
Although the medications lowered targeted risk factors for heart disease, they ultimately proved no more effective than placebos.12
The study outcomes have prompted researchers to re-examine fundamental hypotheses and strategies for treating heart disease.13
Where sources agree
- Experimental drugs failed to lower heart attack or stroke risks3 of 3
- Treatments performed no better than placebos2 of 3
- Trial results raised questions about heart disease strategies2 of 3
Who covered this
3 National
Sources
Based on reporting from these reputable newsrooms and reviewed by Orbit’s editors. A fact appears only when at least two sources report it. Orbit is not affiliated with these publishers.
